Pretax income is the income that a company earns before paying income taxes. Affymax's pretax income for the
three
months ended in Jun. 2014 was $7.21 Mil.
Its pretax income for the trailing twelve months (TTM) ended in Jun. 2014 was $2.69 Mil.
Affymax's pretax margin was 17,164.29%.
Affymax Pre-Tax Income Historical Data
The historical data trend for Affymax's Pre-Tax Income can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Affymax's Pre-Tax Income
For the Biotechnology subindustry, Affymax's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Affymax's Pre-Tax Income Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Affymax's Pre-Tax Income distribution charts can be found below:
* The bar in red indicates where Affymax's Pre-Tax Income falls into.
Affymax Pre-Tax Income Calculation
This is the income that a company earns before paying income taxes.
Affymax's Pretax Income for the fiscal year that ended in Dec. 2013 is calculated as
Pre-Tax Income for the trailing twelve months (TTM) ended in Jun. 2014 adds up the quarterly data reported by the company within the most recent 12 months, which was $2.69 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Affymax (OTCPK:AFFY) Pre-Tax Income Explanation
Affymax's Pretax Margin for the quarter that ended in Jun. 2014 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Affymax Pre-Tax Income Related Terms
Thank you for viewing the detailed overview of Affymax's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.
Affymax Inc is a development-stage biopharmaceutical company, engaged in developing novel peptide-based therapeutics for the treatment of life-threatening conditions. The company's product includes OMONTYS, an injection for the treatment of anemia due to chronic kidney disease in adult patients on dialysis. OMONTYS is a synthetic, peptide-based erythropoiesis stimulating agent, or ESA, designed to stimulate the production of red blood cells and has been the only once-monthly ESA available to the adult dialysis patient population in the U.S.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
AFFY has been successfully added to your 